5.0

Orphus-M Antihistamine & Leukotriene Blocker Tablets | Complete Allergy Relief

Orphus-M combines Levocetirizine 5mg & Montelukast 10mg, a complete antihistamine & leukotriene blocker combination targeting multiple inflammatory pathways for total allergy control against allergic rhinitis, chronic urticaria & asthma in one tablet.

121.88

(MRP Inclusive of all tax)
Product highlights
  • Dual-action Levocetirizine 5mg & Montelukast 10mg formula
  • Complete antihistamine & leukotriene blocker combination
  • Targets multiple inflammatory pathways simultaneously
  • Effectively treats itching, redness & swelling
  • Comprehensive allergic rhinitis & urticaria management
  • Clinically effective for asthma & allergic conjunctivitis
  • Controls exercise-induced bronchoconstriction
  • Dermatologist & physician recommended allergy tablet

100% Genuine Product

100% Clinical Prove

Easy returns & Refund

100% Secure Payment

Cash on Delivery

Key Features
  • Dual-Action Total Control: Levocetirizine & Montelukast work synergistically, simultaneously blocking histamine & leukotriene pathways for complete, comprehensive allergy control
  • Multi-Pathway Targeting: Uniquely targets multiple inflammatory pathways involved in allergic diseases, delivering more comprehensive allergy control than single-ingredient antihistamine tablets
  • Complete Symptom Relief: Effectively treats itching, redness & swelling, providing fast, comprehensive relief from multiple allergic condition symptoms simultaneously
  • Antihistamine Power: Levocetirizine 5mg delivers potent H1 antihistamine action, blocking histamine-driven allergic reactions for effective urticaria & allergic rhinitis control
  • Leukotriene Blocker: Montelukast 10mg blocks leukotriene receptors, controlling airway inflammation & allergic responses for asthma & bronchoconstriction management
  • Broad Indication Coverage: Comprehensively indicated for allergic rhinitis, chronic urticaria, allergic conjunctivitis, asthma & exercise-induced bronchoconstriction
Ingredients
  • Levocetirizine 5mg: Potent H1 antihistamine, blocks histamine receptors for effective urticaria, allergic rhinitis & conjunctivitis control
  • Montelukast 10mg: Leukotriene receptor antagonist, blocks inflammatory leukotriene pathways for asthma & bronchoconstriction management
Clinically Indicated For
  • Allergic Rhinitis: Dual antihistamine & leukotriene blocker controls allergic rhinitis, relieving sneezing, congestion & nasal inflammation effectively
  • Chronic Urticaria: Potent antihistamine action controls histamine-driven chronic urticaria, relieving hives, itching & skin inflammation
  • Allergic Conjunctivitis: Controls histamine-driven eye allergies, relieving redness, itching & watering eyes effectively
  • Asthma Management: Montelukast blocks leukotriene-driven airway inflammation, supporting comprehensive asthma symptom management
  • Exercise-Induced Bronchoconstriction: Leukotriene blocker prevents exercise-induced airway constriction, supporting respiratory comfort during physical activity
Directions to Use
  • Take one Orphus-M tablet orally once daily
  • Best taken in the evening with or without food
  • Swallow whole with a full glass of water
  • Do not exceed the recommended dosage without medical advice
  • Use consistently for sustained allergy control
  • Consult your physician before use for asthma management
  • Do not discontinue without physician guidance
Related products
Team
0 +
Our Products
0 +
Our Customers
0 +
Clinically Proven
0 %

Frequently Asked Question

What is the Orphus-M tablet used for?

Orphus-M Tablet is used to manage allergic conditions such as allergic rhinitis, chronic urticaria (hives), allergic conjunctivitis, and exercise-induced bronchoconstriction. Its dual-action combination of Levocetirizine and Montelukast helps relieve sneezing, itching, redness, swelling, and other allergy symptoms while supporting comprehensive allergy control.

Orphus-M combines Levocetirizine 5 mg and Montelukast 10 mg in a single tablet, providing dual-action allergy control by targeting both histamine and leukotriene pathways. In contrast, Orphus-5 and Orphus-10 contain different formulations and are prescribed based on the patient’s specific condition and treatment needs.

Yes, Orphus-M Tablet is clinically used to help manage allergic rhinitis. Its combination of Levocetirizine and Montelukast works by blocking histamine and leukotriene pathways, helping relieve symptoms such as sneezing, runny nose, nasal congestion, and itching.

Yes, Orphus-M Tablet may help manage exercise-induced bronchoconstriction when prescribed by a healthcare professional. Its Montelukast component blocks leukotriene receptors involved in airway inflammation, helping reduce exercise-triggered airway narrowing and support better breathing as part of an appropriate treatment plan.

Orphus-M Tablet combines Levocetirizine and Montelukast to target both histamine and leukotriene pathways involved in allergic reactions. This dual-action approach provides more comprehensive allergy control than a single antihistamine alone, helping relieve symptoms such as sneezing, itching, nasal congestion, redness, and swelling.

Orphus-M Tablet may cause drowsiness in some individuals due to its Levocetirizine component, although not everyone experiences this effect. If you feel sleepy after taking the tablet, avoid driving or operating machinery. For safe and effective use, take Orphus-M Tablet exactly as prescribed by your healthcare professional.

0
    0
    Your Cart
    Your cart is empty